These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27317841)

  • 1. Long-Term Survival and Apolipoprotein A1 Level in Chronic Heart Failure: Interaction With Tumor Necrosis Factor α -308 G/A Polymorphism.
    Gombos T; Förhécz Z; Pozsonyi Z; Jánoskuti L; Prohászka Z; Karádi I
    J Card Fail; 2017 Feb; 23(2):113-120. PubMed ID: 27317841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol. Predictive value for CHD severity and prognostic utility in CHD patients.
    Liting P; Guoping L; Zhenyue C
    Herz; 2015 Mar; 40 Suppl 1():1-7. PubMed ID: 25374385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined use of apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol before routine clinical lipid measurement in predicting coronary heart disease.
    Pan L; Lu G; Chen Z
    Coron Artery Dis; 2014 Aug; 25(5):433-8. PubMed ID: 24608795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent and additive prognostic ability of serum carboxy-terminal telopeptide of collagen type-I in heart failure patients: a multi-marker approach with high-negative predictive value to rule out long-term adverse events.
    Tziakas DN; Chalikias GK; Stakos D; Chatzikyriakou SV; Papazoglou D; Mitrousi K; Lantzouraki A; Thomaidi A; Boudoulas H; Konstantinides S
    Eur J Prev Cardiol; 2012 Feb; 19(1):62-71. PubMed ID: 20479644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically elevated apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease.
    Haase CL; Tybjærg-Hansen A; Grande P; Frikke-Schmidt R
    J Clin Endocrinol Metab; 2010 Dec; 95(12):E500-10. PubMed ID: 20826588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure.
    Fu S; Xie L; Li D; Ye P; Luo L
    Clin Interv Aging; 2015; 10():359-65. PubMed ID: 25670892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study.
    Eurlings LW; Sanders-van Wijk S; van Kraaij DJ; van Kimmenade R; Meeder JG; Kamp O; van Dieijen-Visser MP; Tijssen JG; Brunner-La Rocca HP; Pinto YM
    J Card Fail; 2014 Dec; 20(12):881-90. PubMed ID: 25175696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype.
    Swanson CR; Li K; Unger TL; Gallagher MD; Van Deerlin VM; Agarwal P; Leverenz J; Roberts J; Samii A; Gross RG; Hurtig H; Rick J; Weintraub D; Trojanowski JQ; Zabetian C; Chen-Plotkin AS
    Mov Disord; 2015 May; 30(6):805-12. PubMed ID: 25227208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and predictors of in-hospital mortality in 270 consecutive patients hospitalised due to acute heart failure in a single cardiology centre during one year.
    Biegus J; Zymliński R; Szachniewicz J; Siwołowski P; Pawluś A; Banasiak W; Jankowska EA; Ponikowski P
    Kardiol Pol; 2011; 69(10):997-1005. PubMed ID: 22006596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise duration and peak systolic blood pressure are predictive of mortality in ambulatory patients with mild-moderate chronic heart failure.
    Williams SG; Jackson M; Ng LL; Barker D; Patwala A; Tan LB
    Cardiology; 2005; 104(4):221-6. PubMed ID: 16158008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of low serum levels of apolipoprotein A-I with adverse outcomes in patients with nonischemic heart failure.
    Iwaoka M; Obata JE; Abe M; Nakamura T; Kitta Y; Kodama Y; Kawabata K; Takano H; Fujioka D; Saito Y; Kobayashi T; Hasebe H; Kugiyama K
    J Card Fail; 2007 May; 13(4):247-53. PubMed ID: 17517342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic utility of the Seattle Heart Failure Score and amino terminal pro B-type natriuretic peptide in varying stages of systolic heart failure.
    Adlbrecht C; Hülsmann M; Neuhold S; Strunk G; Pacher R
    J Heart Lung Transplant; 2013 May; 32(5):533-8. PubMed ID: 23453573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure.
    Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
    J Card Fail; 2013 Jan; 19(1):31-9. PubMed ID: 23273592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
    Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
    Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased serum apolipoprotein A1 level predicts poor prognosis of patients with de novo myelodysplastic syndromes.
    Shi C; Gong S; Wu A; Yang S; Zou D; Zhang Y; Wu N; Ma C; Shi S; Chen Y; Wu Y; Zheng X; Huang Z; Ding J; Ouyang G; Mu Q
    BMC Cancer; 2022 Jan; 22(1):127. PubMed ID: 35100989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure.
    Rauchhaus M; Koloczek V; Volk H; Kemp M; Niebauer J; Francis DP; Coats AJ; Anker SD
    Int J Cardiol; 2000; 76(2-3):125-33. PubMed ID: 11104867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of NT-proBNP in heart failure with preserved versus reduced EF.
    Kang SH; Park JJ; Choi DJ; Yoon CH; Oh IY; Kang SM; Yoo BS; Jeon ES; Kim JJ; Cho MC; Chae SC; Ryu KH; Oh BH;
    Heart; 2015 Dec; 101(23):1881-8. PubMed ID: 26319121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Apolipoprotein A1, High Density Lipoprotein Cholesterol, and Their Ratio with Inflammatory Marker in Chinese Adults with Coronary Artery Disease.
    Dong H; Wang J; Hu P; Lu N
    Angiology; 2023 Sep; 74(8):765-773. PubMed ID: 36065748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.